NCT01583426
- Conditions
- Adenocarcinoma, Breast Cancer Female NOS, Breast Diseases, +19 more
- Locations
-
- Helios-Klinikum Berlin-Buch Berlin, Germany
Clinical trial condition
HER-2 Positive Breast Cancer
Explore clinical trials studying HER-2 Positive Breast Cancer. Study availability and eligibility vary by location and protocol.
19 public trials
1 recruiting study
HER-2 Positive Breast Cancer trial results
Completed
A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases
NCT01305941
- Conditions
- Brain Diseases, Brain Neoplasms, Breast Diseases, +10 more
- Locations
-
- University Of Alabama at Birmingham Birmingham, Alabama, United States
- UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
- Carolinas Healthcare System Charlotte, North Carolina, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
NCT01426880
- Conditions
- Adenocarcinoma, Breast Cancer Female NOS, Breast Diseases, +19 more
- Locations
-
- Praxis Dr. Heinrich Fürstenwalde, Brandenburg, Germany
- Luisenkrankenhaus Düsseldorf, North Rhine-Westphalia, Germany
- NCT Heidelberg Heidelberg, Germany
NCT01677455
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
- Locations
-
- Synta Pharmaceuticals Investigative Site Birmingham, Alabama, United States
- Synta Pharmaceuticals Investigative Site Altanta, Georgia, United States
- Synta Pharmaceuticals Investigative Site Boston, Massachusetts, United States
- Synta Pharmaceuticals Investigative Site New York, United States
NCT01432223
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- Osaka Medical College Takatsuki, Osaka, Japan
NCT01433926
- Conditions
- Breast Diseases, Breast Neoplasms, Disease Attributes, +9 more
- Locations
-
- Hospital oncológico de Galicia A Coruña, Spain
- Hospital de Alcoy Virgen de los Lirios Alcoy, Alicante, Spain
- Hospital Son Llatzer Palma de Mallorca, Balearic Islands, Spain
- Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
Active, Not Recruiting
T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA
NCT02326974
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Tennessee Oncology/Sarah Cannon Research Institute Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
Active, Not Recruiting
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
NCT02947685
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive Breast Cancer, +5 more
- Locations
-
- UCSF San Francisco, California, United States
- Georgetown University Medical Center Washington D.C., District of Columbia, United States
- Baycare Healthcare (Morton Plant Mease) Clearwater, Florida, United States
- Memorial Healthcare System Hollywood, Florida, United States
Active, Not Recruiting
Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer
NCT02568839
- Conditions
- Breast Diseases, Breast Neoplasms, Early-Stage Breast Carcinoma, +5 more
- Locations
-
- Dept. of Oncology, Örebro University Hospital Örebro, Närke, Sweden
- Dept. of Oncology, Sahlgrenska University Hospital Gothenburg, Sweden
- Dept. of Oncology, Skåne University Hospital Lund, Sweden
- Dept. of Oncology, Karolinska University Hospital Stockholm, Sweden